In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer a window into research activities in the women’s health space. They discuss the rise in patenting of female-specific inventions, and consider female representation in patent inventorship.

You can read our full article on the same topic here.

In today's podcast, Richard Pinckney and Naoise Gaffney disseminate the key takeaways from the Supreme Court's decision in Emotional Perception AI v Comptroller General, which has brought about a seismic shift in the way that patentability of Computer Implemented Inventions is to be assessed in the UK.

This is a follow-up to Naoise's stop press article last week on the same topic. Click here to read it now.

Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical device, the EU Medical Device Regulation imposes onerous obligations. In addition, the AI Act, as it stands, add additional regulatory requirements for devices including AI.

In this podcast Xisca Borrás and Ellie Handy discuss when software will qualify as a medical device, the regulatory obligations for devices and the challenges Femtech manufacturers may face in complying with them. They then cover the interaction between the EU MDR and AI Act, discussing how to navigate them.

In view of the European Commission’s proposal to simplify the rules applicable to medical devices, issued after the recording of this podcast, the impact of the AI Act on medical devices may change significantly in the future, so stay tuned for more updates about the changing landscape that applies to AI.

The FemTech sector, which focuses on technology for women’s health and wellness, is experiencing rapid growth in the UK. Out of the 540 active FemTech start-ups in Europe in 2023, 31.8% were based in the UK, and the UK is ranked second globally (behind the US) in terms of investment in the FemTech sector.

In this podcast, Sophie Rees, Anna Honey and Gabriela Necula outline the main early-stage funding options available to UK-based FemTech companies and highlights key legal considerations at each stage.

Finding reasons to be cheerful…hear our tax team’s key takeaways from the Budget 2025 which was announced on Wednesday, 26 November 2025.

After much speculation and the odd leak, we unpick the negative predictions that did not come to pass and share our top three tax ‘good news’ stories.

All information was correct at the time of recording.

In this episode of our Spotlight on Women's Health and Innovation podcast, Laura Harwood and Melissa Dix explore how university spin-outs can offer an effective mechanism for commercialising research, particularly in the women’s health space. They discuss the way in which university spin-outs are bringing research-driven solutions to market, and examine the key contractual considerations regarding the associated IP.

In the very first episode of our Spotlight on Women's Health and Innovation podcast, data protection associates Kiran Sidhu and Subha Kumar discuss how to navigate key GDPR challenges in the women’s health space. They offer practical advice when launching a new product or service in this sector and give top-tips on how to stay compliant and avoid regulatory traps.

In the third and final episode of our series exploring Corporate Law and AI, our experts, Partner Nick Cross and Associate Oliver Alsop, delve into a crucial piece of legislation for anyone considering investing in UK companies in the AI sector: the National Security Investment Act 2021 (NSIA).